← Back to catalogue

MERIFLUOR Pneumocystis

FDA UDI

Class II (US FDA UDI)

by Meridian Bioscience, Inc.

Identity

Trade Name
MERIFLUOR Pneumocystis FDA UDI
Generic Name
Pneumocystis jirovecii antigen IVD, kit, direct fluorescent test (DFT) FDA UDI
Device Name
MERIFLUOR Pneumocystis is an in vitro direct immunofluorescent detection of Pneumocystis carinii cysts and trophozoites in direct smears of respiratory tract specimens. FDA UDI
Model / Reference
222030 FDA UDI
Description
MERIFLUOR Pneumocystis is an in vitro direct immunofluorescent detection of Pneumocystis carinii cysts and trophozoites in direct smears of respiratory tract specimens. FDA UDI

Identifiers

Catalog Number
222030 FDA UDI
Primary DI / UDI-DI
00840733101106 FDA UDI
FDA Product Code
LYF FDA UDI
GMDN Term
Pneumocystis jirovecii antigen IVD, kit, direct fluorescent test (DFT) FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3780 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Pneumocystis jirovecii antigen IVD, kit, direct fluorescent test (DFT)

MERIFLUOR Pneumocystis by Meridian Bioscience, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Pneumocystis jirovecii antigen IVD, kit, direct fluorescent test (DFT).

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 4e952ab4-4ef9-477f-b6ec-d3d374297d9d 36 fields · synced May 30, 2026